Hepatitis Be Virus Antigen
Also known as: HBEAG
Use
The Hepatitis Be Virus Antigen (HBeAg) test monitors the effectiveness of therapy in patients with Hepatitis B virus (HBV) infection. It is typically ordered alongside other HBV markers such as HBV DNA, HBV surface antigen, HBV surface antibody, and HBe antibody. A positive result indicates active viral replication and high infectivity, thus providing essential information for managing chronic hepatitis B.
Special Instructions
Not provided.
Limitations
This assay should not be used for blood donor screening, associated reentry protocols, or for screening human cells, tissues, and cellular- and tissue-based products (HCT/P). Specimens that are heat-inactivated, severely hemolyzed, lipemic, or contain particulate material are unacceptable. Furthermore, the test may yield falsely positive results in samples from patients with rheumatoid factor.
FDA ApprovedNew York Approved
Methodology
Immunoassay (CLIA)
Biomarkers
Hepatitis Be Antigen
Protein
LOINC Codes
- 13954-3 - HBV e Ag SerPl Ql IA
Result Turnaround Time
1 day
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1.0 mL
Minimum Volume
0.6 mL
Container
Serum separator tube (SST).
Storage Instructions
Refrigerated.
Causes for Rejection
Heat-inactivated, severely hemolyzed, lipemic specimens, or specimens containing particulate material.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 24 hours |
| Refrigerated | 7 days |
| Frozen | 30 days (avoid repeated freeze/thaw cycles) |
Other tests from different labs that may be relevant